Starting Your Path to Parenthood? Let us guide you
PGT-A (Preimplantation Genetic Testing for Aneuploidies)
At Ferty9, we're pioneers in offering the revolutionary PGT-A, a groundbreaking genetic screening technique. This advanced method allows us to comprehensively examine embryos created through IVF for chromosomal abnormalities, ensuring the selection of the healthiest and most viable embryos for implantation. PGT-A empowers prospective parents to make informed decisions, minimizing the risk of miscarriages and enhancing the chances of a successful pregnancy. Our skilled team employs state-of-the-art technology to ensure the accuracy and reliability of the results. With PGT-A, we're not just making strides in reproductive science; we're nurturing the potential for healthy, happy families.
PGT-M (Preimplantation Genetic Testing for Monogenic/Single Gene Disorders):
Ferty9's commitment to genetic excellence extends to PGT-M, a transformative solution for couples with a history of hereditary conditions. With PGT-M, we can meticulously screen embryos for specific genetic mutations, ensuring that only unaffected embryos are chosen for implantation. This groundbreaking technique is a testament to our dedication to offering comprehensive fertility solutions, even in the face of genetic challenges. Ferty9's skilled geneticists work in harmony with our fertility experts to provide couples with the peace of mind they deserve on their journey to parenthood.
PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements):
Experience the pinnacle of genetic technology with Ferty9's PGT-SR, a remarkable technique designed to assist couples with structural chromosomal rearrangements. By carefully analyzing embryos for these rearrangements, we're able to identify the ones that are genetically balanced, ensuring a higher likelihood of a successful pregnancy. Our skilled genetic specialists employ cutting-edge methodologies to ensure precision and accuracy in identifying the healthiest embryos for implantation. With PGT-SR, Ferty9 is making strides not only in fertility treatment but also in the realm of genetic empowerment, guiding you towards a future filled with healthy possibilities.
FAQ's
What is genetic testing?
Genetic testing is a medical diagnostic procedure that examines a person's genes, chromosomes, or proteins to identify any changes or mutations that may be present. These tests help determine the risk of developing certain genetic conditions or assess the likelihood of passing on these conditions to future generations. Genetic testing plays a critical role in reproductive medicine, helping individuals and couples make informed choices about their fertility issues and family planning options.
What is PGT
Preimplantation Genetic Testing (PGT) is a specialised type of genetic testing conducted on embryos created through in vitro fertilisation (IVF). PGT includes analysing a small number of cells from the embryo to identify genetic abnormalities or mutations. This advanced technology allows fertility specialists to select the healthiest embryos for transfer, increasing the possibilities of a successful pregnancy and lowering the risk of genetic diseases in offspring.
Who should get the genetic testing done
Fertility professionals generally recommend genetic testing for couples who have a known family history of genetic disorders or are carriers of specific genetic mutations. It can also be beneficial for individuals or couples who have a history of recurrent miscarriages, failed IVF attempts, or advanced maternal age. By identifying potential genetic issues before embryo transfer, PGT provides valuable information that helps fertility specialists tailor treatment plans and improve the chances of a successful pregnancy.
What is PGT-A (Preimplantation Genetic Testing for Aneuploidy)
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a specific type of genetic testing that screens embryos for chromosomal abnormalities, such as aneuploidy. Aneuploidy indicates an abnormal number of chromosomes in an embryo, which can result in implantation failure, miscarriages, or the birth of a child with genetic disorders. By recognising embryos with the correct number of chromosomes, PGT-A enables embryologists to select the most viable embryos for transplantation, increasing the chances of a successful pregnancy.
What is PGT-M (Preimplantation Genetic Testing for Monogenic Disorders)?
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a specialised method to help identify specific gene mutations or single gene disorders in embryos. Healthcare professionals recommend this type of testing for couples who are potential carriers of genetic disorders, such as autosomal recessive, autosomal dominant, and X-linked disorders. PGT-M allows embryologists to select embryos that are free from these genetic disorders, reducing the possibility of passing them on to future generations. It provides hope for couples who have a high risk of having a child with a severe genetic condition.
What is PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements)?
Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) is a specialised genetic testing technique that helps detect structural abnormalities in embryos. Structural rearrangements refer to changes in the structure of chromosomes, such as translocations or inversions, which can result in implantation failure, miscarriage, or the birth of a child with genetic disorders. PGT-SR allows embryologists to identify embryos with these structural rearrangements and select those with a higher possibility of successful implantation and a lower risk of genetic disorders.
